GulfBase Live Support
Gulf Pharmaceutical Industries (known as: Julphar) is a public company based in Ras Al Khaimah (UAE) and was established in March 1980. Julphar is listed on the Abu Dhabi Securities Exchange since July 2005, and is the largest generic pharmaceutical manufacturer in the Middle East and North Africa, distributing medicines to over 40 countries. It operates within the pharmaceuticals, biotechnology and life sciences sector, focusing on pharmaceuticals. The company is engaged in the manufacture of medicines, drugs and various other types of pharmaceutical, medical and cosmetic compounds. It has 6 subsidiaries operating across UAE, South Africa, Bangladesh and Germany. The company's plant is located in the city of Ras Al Khaimah where its headquarters are also located. It was established with a goal to create high-quality medicines, whilst maintaining a competitive cost. It has also launched manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia as part of its ongoing international expansion strategy. Julphar maintain a diverse product portfolio which targetsmainly the therapeutic segments, including: Wound, Adult Primary Care, Cardiopulmonary Care, Anemia and Women Care, Gastro Care, Pediatric Primary Care, Pain Management and Consumer Care. Moreover, it is the only company in the Middle East to produce the raw material needed to make insulin through our division dedicated to diabetes.
Abdullah F. Al Qasimi
Ahmad I. Al Naeem
Ahmad S. A. Alhosani
Ali H. A. Al Zawawi
Jamal S. D. Al Nuaimi
Nawaf G. A. Said
Sh. Saqr H. A. Al Qasimi
Julphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical ...Read More ...
Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales ...Read More ...
Julphar Gulf Pharmaceutical Industries on Sunday said its net profit for the third quarter of this ...Read More ...
|Announced On||Period||As Of||Net Profit (SAR Mil)||Growth (%)|
|Price Change (%)
|Price Change (%)
|P/E TTM||P/B MRQ||Dividend Yield (%)||Beta||ROA (%)||ROE (%)|